New online program aims to stop eating disorders in women with type 2 diabetes
NCT ID NCT07468188
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 6-week virtual program called the Diabetes Body Project 2, designed to prevent eating disorders in women aged 18-40 with type 2 diabetes. The program includes weekly group sessions and home exercises to improve body image and reduce disordered eating. Researchers want to see if it also helps with blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Body Project Type 2 (behavioral intervention)
- What this could lead to
- If it works, this could provide an effective, scalable program to reduce eating disorders and improve body image in women with type 2 diabetes.
- What could go wrong
- This is a small, early feasibility study with only 42 participants, so results may not apply to everyone. The program is behavioral and may not work for all individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EATING DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Joslin Diabetes Center
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a gentle Head-Zap calm the fear of mealtimes?
- Can a single pill tackle both fatty liver and diabetes?